ACADIA Pharmaceuticals
ACAD
#3255
Rank
NZ$7.73 B
Marketcap
NZ$45.75
Share price
-0.37%
Change (1 day)
47.10%
Change (1 year)

Market capitalization of ACADIA Pharmaceuticals (ACAD)

Market cap: NZ$7.73 Billion

As of December 2025 ACADIA Pharmaceuticals has a market cap of NZ$7.73 Billion. This makes ACADIA Pharmaceuticals the world's 3255th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ACADIA Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$7.73 B54.77%
2024NZ$5.00 B-38.48%
2023NZ$8.12 B100.19%
2022NZ$4.06 B-26.08%
2021NZ$5.49 B-53.36%
2020NZ$11.77 B19.42%
2019NZ$9.86 B184.42%
2018NZ$3.46 B-34.15%
2017NZ$5.26 B4.43%
2016NZ$5.04 B-5.03%
2015NZ$5.30 B30.97%
2014NZ$4.05 B46.34%
2013NZ$2.77 B568.35%
2012NZ$0.41 B467.33%
2011NZ$73.06 M19.37%
2010NZ$61.2 M-12.14%
2009NZ$69.66 M20.82%
2008NZ$57.65 M-89.23%
2007NZ$0.53 B43.28%
2006NZ$0.37 B53.88%
2005NZ$0.24 B51.89%
2004NZ$0.15 B

End of Day market cap according to different sources

On Dec 11th, 2025 the market cap of ACADIA Pharmaceuticals was reported to be:

NZ$7.76 Billion
by Nasdaq info icon info icon
NZ$7.76 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Vanda Pharmaceuticals
VNDA
NZ$0.64 B-91.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$253.80 B 3,179.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.577 T 20,283.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$874.61 B 11,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$184.71 B 2,286.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
NZ$0.64 B-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA